GT200500385A - TRICYCLE AMINOALCOHOLES, PROCEDURES FOR PREPARATION AND USE AS INFLAMMATION INHIBITORS - Google Patents

TRICYCLE AMINOALCOHOLES, PROCEDURES FOR PREPARATION AND USE AS INFLAMMATION INHIBITORS

Info

Publication number
GT200500385A
GT200500385A GT200500385A GT200500385A GT200500385A GT 200500385 A GT200500385 A GT 200500385A GT 200500385 A GT200500385 A GT 200500385A GT 200500385 A GT200500385 A GT 200500385A GT 200500385 A GT200500385 A GT 200500385A
Authority
GT
Guatemala
Prior art keywords
aminoalcoholes
procedures
preparation
tricycle
inflammation inhibitors
Prior art date
Application number
GT200500385A
Other languages
Spanish (es)
Inventor
Markus Berger
Norbert Schmees
Heike Schacke
Stefan Baurle
Hartmut Rehwinkel
Anne Mengel
Konrad Krolikiewicz
Danja Grossbach
David Voigtlander
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of GT200500385A publication Critical patent/GT200500385A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/517—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with carbocyclic ring systems, e.g. quinazoline, perimidine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/70—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings condensed with carbocyclic rings or ring systems
    • C07D239/72—Quinazolines; Hydrogenated quinazolines
    • C07D239/74—Quinazolines; Hydrogenated quinazolines with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, attached to ring carbon atoms of the hetero ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
    • C07D311/06—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 2
    • C07D311/20—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 2 hydrogenated in the hetero ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/78—Ring systems having three or more relevant rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links

Abstract

LA PRESENTE INVENCIÓN SE REFIERE A AMINOALCOHOLES TRICÍCLICOS, A PROCEDIMIENTOS PARA SU PREPARACIÓN Y A SU USO COMO INHIBIDORES DE INFLAMACIÓN.THIS INVENTION REFERS TO TRICYCLIC AMINOALCOHOLES, PROCEDURES FOR THEIR PREPARATION AND THEIR USE AS INFLAMMATION INHIBITORS.

GT200500385A 2004-12-22 2005-12-22 TRICYCLE AMINOALCOHOLES, PROCEDURES FOR PREPARATION AND USE AS INFLAMMATION INHIBITORS GT200500385A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE102004063227A DE102004063227A1 (en) 2004-12-22 2004-12-22 Tricylic amino alcohols, process for their preparation and their use as anti-inflammatory agents

Publications (1)

Publication Number Publication Date
GT200500385A true GT200500385A (en) 2006-08-03

Family

ID=36250953

Family Applications (1)

Application Number Title Priority Date Filing Date
GT200500385A GT200500385A (en) 2004-12-22 2005-12-22 TRICYCLE AMINOALCOHOLES, PROCEDURES FOR PREPARATION AND USE AS INFLAMMATION INHIBITORS

Country Status (14)

Country Link
JP (1) JP2008524300A (en)
KR (1) KR20070089948A (en)
CN (1) CN101087780A (en)
AR (1) AR055016A1 (en)
AU (1) AU2005318354A1 (en)
BR (1) BRPI0519710A2 (en)
CA (1) CA2586973A1 (en)
DE (1) DE102004063227A1 (en)
GT (1) GT200500385A (en)
IL (1) IL183060A0 (en)
MX (1) MX2007007420A (en)
PA (1) PA8657801A1 (en)
PE (1) PE20061197A1 (en)
WO (1) WO2006066950A2 (en)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7662821B2 (en) 2003-10-08 2010-02-16 Bayer Schering Pharma Ag Tetrahydronaphthalene derivatives, process for their production and their use as anti-inflammatory agents
ATE348609T1 (en) 2003-10-08 2007-01-15 Schering Ag TETRAHYDRONAPHTHALINE DERIVATIVES, METHOD FOR THE PRODUCTION THEREOF AND THEIR USE AS ANTI-INFLAMMATORY
US7638515B2 (en) 2003-10-08 2009-12-29 Bayer Schering Pharma Aktiengesellschaft Tetrahydronaphthalene derivatives, process for their production and their use as anti-inflammatory agents
US20080153859A1 (en) 2004-04-05 2008-06-26 Hartmut Rehwinkel Multiply-substituted tetrahydronaphthalene derivatives, process for their production and their use as anti-inflammatory agents
US7297700B2 (en) 2005-03-24 2007-11-20 Renovis, Inc. Bicycloheteroaryl compounds as P2X7 modulators and uses thereof
EP1834948A1 (en) 2006-03-15 2007-09-19 Bayer Schering Pharma Aktiengesellschaft Tetrahydronaphtalene derivatives, methods for the production thereof, and their use as antiinflammatory drugs
TWI464148B (en) 2006-03-16 2014-12-11 Evotec Us Inc Bicycloheteroaryl compounds as p2x7 modulators and uses thereof
EP1917963A1 (en) * 2006-10-31 2008-05-07 Bayer Schering Pharma Aktiengesellschaft Cyclic phenyl-substituted indazols, a process for their production and their use as anti-inflammatory agents
EP2072509A1 (en) 2007-12-18 2009-06-24 Bayer Schering Pharma Aktiengesellschaft 1-Aryl-1H-quinoline-2-ones: process for their production and their use as anti-inflammatory agents
US10189825B2 (en) 2012-02-08 2019-01-29 Sunovion Pharmaceuticals Inc. Heteroaryl compounds and methods of use thereof
JP7187437B2 (en) 2016-07-29 2022-12-12 サノビオン ファーマシューティカルズ インク Compounds and compositions and uses thereof
MA45795A (en) 2016-07-29 2019-06-05 Sunovion Pharmaceuticals Inc COMPOUNDS AND COMPOSITIONS, AND ASSOCIATED USES
MX2020000523A (en) 2017-08-02 2020-08-20 Sunovion Pharmaceuticals Inc Isochroman compounds and uses thereof.
KR20210139376A (en) 2019-03-14 2021-11-22 선오비온 파마슈티컬스 인코포레이티드 Salts of isochromanyl compounds, and crystalline forms thereof, methods of preparation, therapeutic uses and pharmaceutical compositions
KR102462991B1 (en) * 2020-11-02 2022-11-04 한국해양과학기술원 Compound from a Antarctic-Derived Fungal Strains Acremonium sp. SF-7394 and Composition for Anti-Inflammation, Anticancer or Anti-Diabetes Comprising the Same

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10038639A1 (en) * 2000-07-28 2002-02-21 Schering Ag New and known N-aryl 2-hydroxy-omega-arylalkanamide derivatives, useful e.g. for treating inflammatory diseases such as rheumatism
ATE381333T1 (en) * 2002-03-26 2008-01-15 Boehringer Ingelheim Pharma GLUCOCORTICOID MIMETICS, THEIR PREPARATION, PHARMACEUTICAL COMPOSITIONS AND USE
DE10215316C1 (en) * 2002-04-02 2003-12-18 Schering Ag Quinoline and isoquinoline derivatives, a pharmaceutical agent and their use as anti-inflammatory agents
ATE348609T1 (en) * 2003-10-08 2007-01-15 Schering Ag TETRAHYDRONAPHTHALINE DERIVATIVES, METHOD FOR THE PRODUCTION THEREOF AND THEIR USE AS ANTI-INFLAMMATORY
GB0418045D0 (en) * 2004-08-12 2004-09-15 Glaxo Group Ltd Compounds
DE102004044680B3 (en) * 2004-09-09 2006-06-08 Schering Ag Alkylidene tetrahydronaphthalene derivatives, process for their preparation and their use as anti-inflammatory agents and pharmaceutical compositions containing them

Also Published As

Publication number Publication date
WO2006066950A3 (en) 2006-08-17
CA2586973A1 (en) 2006-06-29
KR20070089948A (en) 2007-09-04
BRPI0519710A2 (en) 2009-03-10
CN101087780A (en) 2007-12-12
AU2005318354A1 (en) 2006-06-29
IL183060A0 (en) 2007-09-20
MX2007007420A (en) 2007-07-17
PA8657801A1 (en) 2006-12-07
AR055016A1 (en) 2007-08-01
WO2006066950A2 (en) 2006-06-29
JP2008524300A (en) 2008-07-10
DE102004063227A1 (en) 2006-07-06
PE20061197A1 (en) 2006-12-07

Similar Documents

Publication Publication Date Title
GT200500385A (en) TRICYCLE AMINOALCOHOLES, PROCEDURES FOR PREPARATION AND USE AS INFLAMMATION INHIBITORS
CR20150586A (en) TRICYCLE COMPOUNDS CONTAINING NITROGEN AS ANTIBACTERCIAN AGENTS
UY33124A (en) AGENTS AND EPITHES LINKED TO WISE
GT200800250A (en) ARILIMIDAZOLONAS AND ARILTRIAZOLONAS REPLACED AS INHIBITORS OF VASOPRESINE RECEPTORS
CO6321189A2 (en) BENCEN-SULFONAMIDE TIAZOL AND OXAZOL COMPOUNDS
DOP2010000328A (en) BACE INHIBITORS
PA8718601A1 (en) ANTI-5T4 ANTIBODIES AND THEIR USES
CR10328A (en) ORGANIC COMPOUNDS
DOP2011000171A (en) ORGANIC COMPOUNDS
UY30319A1 (en) DPP IV INHIBITORS FORMULATIONS
ECSP11011487A (en) PIRAZINILPIRAZOLES
CR9786A (en) BENCIMIDAZOL-THIOPHEN COMPOUNDS
PA8652701A1 (en) DERIVATIVES OF QUINOLIN AND ISOQUINOLIN 5-SUBSTITUTES, A PROCEDURE FOR THEIR PREPARATION AND ITS USE AS INFLAMMATION INHIBITORS
BRPI0814420A2 (en) composition, and use of alkoxylated alcohol.
DOP2007000043A (en) SUBSTITUTED CHROMANOL DERIVATIVES AND THEIR USE
HN2008001723A (en) SIPROCICLIC NITRILS AS PROTEASA INHIBITORS
BRPI0818459A2 (en) Pharmaceutical composition suitable for ophthalmic use.
ECSP088740A (en) TETRAHYDRONAFTALINE DERIVATIVES, PROCEDURES TO PREPARE THEM AND THEIR USE AS ANTI-INFLAMMATORIES
BRPI0907053A2 (en) Polyisobutenoamine, fuel composition, and use of polyisobutenoamines
BRPI1012047A2 (en) oxazolidinone-containing dimer compounds, compositions and methods for making and using
CR11838A (en) COMPOUNDS CONTAINING TRICYCLIC NITROGEN AND ITS USE AS ANTIBACTERIALS
BRPI0921873A2 (en) Plant extracts for use as phytochemicals
PA8806501A1 (en) TRIAZOLOTRIAZINAS AND TRIAZOLOPIRAZINAS AND ITS USE
ECSP10010661A (en) DRONEDARONE FOR THE PREVENTION OF CARDIOVERSION
SV2010003773A (en) 7-SULFANILMETIL-, 7-SULFINILMETIL- AND 7-SULFONILMETILINDOLES REPLACED AND THE USE OF THE SAME